Aggravated dry eye after laser in situ keratomileusis in patients with Sjögren syndrome

Cornea

Volumn 27, Issue 1, 2008, Pages 120-123

  Liang, Lingyi ^a   Zhang, Mei ^b   Zou, Wenjin ^a   Liu, Zuguo ^a,b  

^a SUN YAT SEN UNIVERSITY   (China)

^b XIAMEN UNIVERSITY   (China)

Author keywords

Dry eye; Laser in situ keratomileusis; Sj gren syndrome

Indexed keywords

EYE DROPS; FLUOROMETHOLONE;

ADULT; ARTICLE; CASE REPORT; DRUG COMBINATION; DRY EYE; FEMALE; HUMAN; KERATOMILEUSIS; LACRIMAL APPARATUS; LACRIMAL FLUID; MULTIMODALITY CANCER THERAPY; MYOPIA; SECRETION; SERUM; SJOEGREN SYNDROME;

ADULT; COMBINED MODALITY THERAPY; DRUG THERAPY, COMBINATION; DRY EYE SYNDROMES; FEMALE; FLUOROMETHOLONE; HUMANS; KERATOMILEUSIS, LASER IN SITU; LACRIMAL APPARATUS; MYOPIA; OPHTHALMIC SOLUTIONS; SERUM; SJOGREN'S SYNDROME; TEARS;

EID: 40449100735     PISSN: 02773740     EISSN: 15364798     Source Type: Journal    
DOI: 10.1097/ICO.0b013e318158312f     Document Type: Article

References (16)

1. Albietz JM, Lenton LM. Management of the ocular surface and tear film before, during, and after laser in situ keratomileusis. J Refract Surg. 2004; 20:62-71. (Pubitemid 38101585)
2. Toda I, Asano-Kato N, Komai-Hori Y, et al. Dry eye after laser in situ keratomileusis. Am J Ophthalmol. 2001;132:1-7. (Pubitemid 32600882)
3. Toda I, Asano-Kato N, Komai-Hori Y, et al. Laser in situ keratomileusis for patients with dry eye. Arch Ophthalmol. 2002;120:1024-1028. (Pubitemid 34856069)
4. Smith RJ, Maloney RK. Laser in situ keratomileusis in patients with autoimmune diseases. J Cataract Refract Surg. 2006;32:1292-1295. (Pubitemid 44080473)
5. Mohammadopour M. Excimer laser refractive surgery in patients with underlying autoimmune diseases. J Cataract Refract Surg. 2007;33:175.
6. Kohnen T. Excimer laser refractive surgery in autoimmune diseases. J Cataract Refract Surg. 2006;32:1241. (Pubitemid 44080496)
7. Alio JL, Artola A, Belda JI, et al. LASIK in patients with rheumatic diseases: a pilot study. Ophthalmology. 2005;112:1948-1954. (Pubitemid 41551923)
8. Cobo-Soriano R, Beltran J, Baviera J. LASIK outcomes in patients with underlying systemic contraindications: a preliminary study. Ophthalmology. 2006;113:1118-1124.
9. Toda I, Asano-Kato N, Hori-Komai Y, et al. Ocular surface treatment before laser in situ keratomileusis in patients with severe dry eye. J Refract Surg. 2004;20:270-275. (Pubitemid 38657019)
10. Dogru M, Tsubota K. Sjögren syndrome. In Smolin G, Thoft RA, eds. The Cornea: Scientific Foundation and Clinical Practice. Boston: Little Brown and Co; 1987:629-645.
11. Tsubota K, Goto E, Shimmura S, et al. Treatment of persistent corneal epithelial defect by autologous serum application. Ophthalmology. 1999; 106:1984-1989.
12. Gimbel HV, Levy SG. Indications, results and complications of LASIK. Curr Opin Ophthalmol. 1998;9:3-8.
13. Tsubota K, Fujita H, Tadano K, et al. Improvement of lacrimal function by topical application of CyA in murine models of Sjögren's syndrome. Invest Ophthalmol Vis Sci. 2001;42:101-110. (Pubitemid 32059416)
14. Birgnole F, Pisella PJ, Goldschild M, et al. Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes. Invest Ophthalmol Vis Sci. 2000;41:1356- 1363. (Pubitemid 30261857)
15. Donnenfeld ED, Solomon K, Perry HD, et al. The effect of hinge position on corneal sensation and dry eye after LASIK. Ophthalmology. 2003;110:1023-1029. (Pubitemid 36560506)
16. Vroman DT, Sandoval HP, Fernandez de Castro LE, et al. Effect of hinge location on corneal sensation and dry eye after laser in situ keratomileusis for myopia. J Cataract Refract Surg. 2005;31:1881- 1887. (Pubitemid 41773157)